HONG KONG,Feb. 17,2025 -- This Monday marks the global launch ofSQLFlash,an AI-powered SQL optimization tool designed to help developers and database administrators tackle one of their biggest challenges: slow queries.By leveraging smart analysis and optimization,our product rewrites inefficient SQL statements,provides actionable index recommendations,and visualizes execution plans in an intuitive tree format—all automatically.
Key Features of SQLFlash:
AI-Driven Query Optimization: Rewrites slow SQL queries for improved performance.
Actionable Index Recommendations: Offers targeted suggestions to speed up your database.
Execution Plan Visualization: Displays execution plans in an intuitive tree format for easy understanding.
Multi-Database Support: Compatible with MySQL,Oracle,PostgreSQL,and ORM-generated queries from frameworks like MyBatis and Hibernate.
Non-Invasive Design: Ensures sensitive data never leaves your system.
Built for Developers and Database Administrators
Unlike traditional tools,SQLFlash is praised for its ease of use and educational value. "It's like having a personal SQL tutor," says one early adopter. With performance improvements averaging over 50%,SQLFlash is already being called a game-changer in database management.
Launch Offer
To celebrate its launch,SQLFlash is offering the first 100 registrants free access to its enterprise-grade features. Whether you're optimizing simple queries or tackling complex SQL challenges,SQLFlash promises to save time,reduce costs,and enhance your skills.
Get Started Today
Experience the future of SQL optimization. Visit SQLFlash to claim your free access and revolutionize your database management workflow.
Visit SQLFlash now!
The first 100 registrants can get one month of free membership:
https://sqlflash.chatdba.com/?utm_source=partner_media&utm_medium=social&utm_campaign=productannouncement&utm_content=visit_link
CONTACT: service.sqlflash@chatdba.com
Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share
Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion
LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025
2025 Global Sources Hong Kong Shows: Shaping the Future of Consumer Trends and Redefining Sourcing
©copyright 2009-2020 Singapore Info Map